MoneyWatch

Merck's profit up 7 percent despite sales decline

/ AP

WHITEHOUSE STATION, N.J. - Merck & Co.'s (MRK) first-quarter profit rose 7 percent, as heavy cost-cutting offset lower sales due to generic competition and a tax benefit in last year's quarter.

The maker of the type 2 diabetes pill Januvia says net income was $1.71 billion, or 57 cents per share, up from $1.59 billion, or 52 cents per share, a year earlier.

Excluding one-time items, net income would have been $2.6 billion, or 88 cents per share. Analysts surveyed by FactSet were expecting 79 cents per share.

Revenue totaled $10.26 billion. Analysts expected $10.44 billion.

Merck, based in Whitehouse Station, N.J., reaffirmed its 2014 forecast for profit of $2.15 to $2.47 per share.

First published on April 29, 2014 / 8:00 AM EDT

© 2014 The Associated Press. All Rights Reserved. This material may not be published, broadcast, rewritten, or redistributed.

f

We and our partners use cookies to understand how you use our site, improve your experience and serve you personalized content and advertising. Read about how we use cookies in our cookie policy and how you can control them by clicking Manage Settings. By continuing to use this site, you accept these cookies.